Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Westermark
Giampaolo Merlini

Showing results (351-360 of 587) with videos related to

Pageof 59
Sort By:
Clinical Chemistry and Laboratory Medicine|April 9, 2010
Development and preparation of a new serum protein reference material: feasibility studies and processingIngrid Zegers, Wiebke Schreiber, Sarah Linstead, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 2, 2016
A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndromeVirpi Elisa Raivio, Jenni Jonasson, Liisa Myllykangas, et al.
Acta Dermato-Venereologica|March 15, 2003
Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patientsAgneta Gånemo, Maritta Pigg, Marie Virtanen, et al.
Blood|June 15, 2026
A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosisEfstathios Kastritis, Monique C Minnema, Meletios-Athanasios A Dimopoulos, et al.
Hemasphere|March 25, 2025
Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control studyClaudia Bellofiore, Marco Basset, Giuseppe Damiano Sanna, et al.
Circulation|April 30, 2003
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosisGiovanni Palladini, Carlo Campana, Catherine Klersy, et al.
Arthritis and Rheumatism|June 26, 2008
Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity?Jiska M Meijer, Stefan O Schonland, Giovanni Palladini, et al.
Seminars in Arthritis and Rheumatism|January 8, 2014
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-upLuca Cantarini, Donato Rigante, Giampaolo Merlini, et al.
Proteomics. Clinical Applications|December 8, 2010
Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable resultsFrank Vitzthum, Gérard Siest, David M Bunk, et al.
Journal of the American Society of Nephrology : JASN|October 14, 2005
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritisGina Gregorini, Claudia Izzi, Laura Obici, et al.
Pageof 59

Showing results (351-360 of 587) with videos related to

Sort By:
Pageof 59
Clinical Chemistry and Laboratory Medicine|April 9, 2010
Development and preparation of a new serum protein reference material: feasibility studies and processingIngrid Zegers, Wiebke Schreiber, Sarah Linstead, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 2, 2016
A novel transthyretin Lys70Glu (p.Lys90Glu) mutation presenting with vitreous amyloidosis and carpal tunnel syndromeVirpi Elisa Raivio, Jenni Jonasson, Liisa Myllykangas, et al.
Acta Dermato-Venereologica|March 15, 2003
Autosomal recessive congenital ichthyosis in Sweden and Estonia: clinical, genetic and ultrastructural findings in eighty-three patientsAgneta Gånemo, Maritta Pigg, Marie Virtanen, et al.
Blood|June 15, 2026
A Phase 2 trial of daratumumab monotherapy in newly diagnosed patients with cardiac stage IIIb AL amyloidosisEfstathios Kastritis, Monique C Minnema, Meletios-Athanasios A Dimopoulos, et al.
Hemasphere|March 25, 2025
Daratumumab-based regimens versus CyBorD in newly diagnosed patients with AL amyloidosis and IIIb cardiac stage: A matched case-control studyClaudia Bellofiore, Marco Basset, Giuseppe Damiano Sanna, et al.
Circulation|April 30, 2003
Serum N-terminal pro-brain natriuretic peptide is a sensitive marker of myocardial dysfunction in AL amyloidosisGiovanni Palladini, Carlo Campana, Catherine Klersy, et al.
Arthritis and Rheumatism|June 26, 2008
Sjögren's syndrome and localized nodular cutaneous amyloidosis: coincidence or a distinct clinical entity?Jiska M Meijer, Stefan O Schonland, Giovanni Palladini, et al.
Seminars in Arthritis and Rheumatism|January 8, 2014
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-upLuca Cantarini, Donato Rigante, Giampaolo Merlini, et al.
Proteomics. Clinical Applications|December 8, 2010
Metrological sharp shooting for plasma proteins and peptides: The need for reference materials for accurate measurements in clinical proteomics and in vitro diagnostics to generate reliable resultsFrank Vitzthum, Gérard Siest, David M Bunk, et al.
Journal of the American Society of Nephrology : JASN|October 14, 2005
Renal apolipoprotein A-I amyloidosis: a rare and usually ignored cause of hereditary tubulointerstitial nephritisGina Gregorini, Claudia Izzi, Laura Obici, et al.
Pageof 59